Clinical Heterogeneity of Duchenne Muscular Dystrophy (DMD): Definition of Sub-Phenotypes and Predictive Criteria by Long-Term Follow-Up
Isabelle Desguerre, Christo Christov, Michele Mayer et al. · 2009
Read Clinical Heterogeneity of Duchenne Muscular Dystrophy (DMD): Definition of Sub-Phenotypes and Predictive Criteria by Long-Term Follow-Up by Isabelle Desguerre, Christo Christov, Michele Mayer et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004347.txt.
Description
Isabelle Desguerre and colleagues published this muscular dystrophy study in PLOS ONE in 2009. Duchenne muscular dystrophy varies greatly between patients, and that clinical heterogeneity is a major obstacle to interpreting therapeutic trials. To explore it, the team carried out a retrospective, single-institution, long-term follow-up study of patients with complete lack of muscle dystrophin. All lacked dystrophin, the protein whose absence defines the disease.
From those records they define sub-phenotypes, distinct patterns within the disease, and predictive criteria for how it will unfold. Sorting patients into meaningful groups makes future trials fairer and their results readable.
Catalog record
| CREATOR | Isabelle Desguerre, Christo Christov, Michele Mayer et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004347